This study compares currently enacted and pending legislation and policies concerning genetic information and genetic discrimination in Europe and the USA.
The emergence of a multi-disciplinary scientific field comprising genetically-related areas and the discovery of new genetic factors have improved our ability to predict genetic risks associated with illness.
Early detection and preventive healthcare thus hold promise for improving public health, but much remains unknown about the actual risks deriving from genetic testing.
Positive (not-normal) test results may give little certainty of the actual severity of a disease.
Genetic information could thus be used for social stigmatization and genetic discrimination.
Western laws have been enacted in a context of unknown potential risks and benefits, and an increased number of regulatory initiatives is to be expected.
Yet, there is currently no comprehensive US or European legal approach concerning genetic information and genetic discrimination and, despite legislation thus far enacted, the protection of individuals remains uncertain, and this could have a negative impact on attitudes to genetic testing, with important consequences for public health strategies to prevent disease.
Mots-clés Pascal : Suède, Europe, Système santé, Etats Unis, Amérique du Nord, Amérique, Législation, Politique, Etude comparative, Génétique, Information, Utilisation, Discrimination, Tendance, Analyse, Assurance maladie, Ethique
Mots-clés Pascal anglais : Sweden, Europe, Health system, United States, North America, America, Legislation, Policy, Comparative study, Genetics, Information, Use, Discrimination, Trend, Analysis, Health insurance, Ethics
Notice produite par :
Inist-CNRS - Institut de l'Information Scientifique et Technique
Cote : 99-0423663
Code Inist : 002B30A09. Création : 22/03/2000.